Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 08/07/19971 min de lecture
Medtronic, Inc.; Premarket Approval of the CapSureRegister Epi Pacing Lead, Model 4965
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is announcing its approval of the application submitted by Medtronic, Inc., Minneapolis, MN, for premarket approval, under the Federal Food, Drug, and Cosmetic Act (the act), of the CapSure Epi Pacing Lead, Model 4965. After reviewing the recommendation of the Circulatory System Devices Panel, FDA's Center for Devices and Radiological Health (CDRH) notified the applicant, by letter of September 6, 1996, of the approval of the application.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →